Other strategies to disrupt ASC speck formation and inhibit NLRP3 inflammasome activation that have been tested in AD models and patients involve modulating their metabolism through ketogenic diets, caloric restriction, or fasting [196]. Here, NLRP3 is linked to Alzheimer disease.